Ireland· IE-PA-EU/1/07/422/005-006

Tasigna 150 mg Capsule, hard

A nilotinib product containing nilotinib, registered in Ireland by Novartis Europharm Limited.

ATC L01XE08

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about nilotinibAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

HPRA (Ireland)

Active substance: Nilotinib
Manufacturer: Novartis Europharm Limited
Country: Ireland (IE)
ATC code: L01XE08
ATC class: Nilotinib
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1/07/422/005-006

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

801 interactions on record for nilotinib.

Graded by severity as the source publishes them — 303 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check nilotinib against other medicines How interaction checks work

Nilotinib · interactions on record

801 records

303 severe
433 moderate
20 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

45 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nilotinib in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nilotinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Nilotinib Stada, Nilotinib Teva
Belgium · Nilotinb Eg, Nilotinib
Bulgaria · Нилотиниб Зентива, Нилотиниб Стада
Cyprus · Nilotinib Bioars, Nilotinib Olpha
Czechia · Nilotinib, Nilotinib Stada
Germany · Nilotinib Al, Nilotinib Al 150 Mg Hartkapseln Al
Denmark · Nilotinib "olpha", Nilotinib Stada
Estonia · Nilotinib Olpha, Nilotinib Stada
Spain · Nilotinib Cipla, Nilotinib Eugia
Finland · Nilotinib Stada, Nilotinib Zentiva
France · Nilotinib Arrow, Nilotinib Biogaran
United Kingdom (Northern Ireland) · Nilotinib Amarox, Nilotinib Teva Uk
Greece · Lobynia, Nilotinib Anabiosis
Croatia · Nilmat, Nilotinib Devatis
Hungary · Krufton, Nilotinib
Iceland · Nilotinib, Nilotinib Accord
Italy · Nilotinib Cipla, Nilotinib Eg
Liechtenstein · Nilotinib Accord, Tasigna
Lithuania · Krufton, Nilotinib Olpha
Luxembourg · Nilotinib Eg, Nilotinib Eugia
Latvia · Krufton, Nilotinib Olpha
Malta · Nilotinib Hydrochloride Dihydrate Clonmel, Nilotinib Olpha
Netherlands · Nilotinib Cf, Nilotinib Cipla
Norway · Nilotinib Accord, Nilotinib Cipla
Poland · Nilotinib Stada, Nilotinib Viatris
Portugal · Nilotinib Eugia, Nilotinib Generis
Romania · Krufton, Nilotinib Cipla
Sweden · Nilotinib Cipla, Nilotinib Devatis
Slovenia · Nilmat, Nilotinib Stada
Slovakia · Krufton, Nilotinib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e795659f-d227-4766-879e-07f27c602b39
GET /v1/drugs/e795659f-d227-4766-879e-07f27c602b39?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XE",
    "L01XE08"
  ],
  "strength": null,
  "pa_number": "EU/1/07/422/005-006",
  "substances": [
    "Nilotinib"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": null,
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0195-062-001"
}

API reference MCP server Plans

See everything about nilotinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console